No insider purchase over the last 90 days. The latest, by 戴岚, was filed 26 Mar 2024.
Bide Pharmatech Co., Ltd.: what insiders have been doing
Bide Pharmatech Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). Over the twelve months to 5 November 2026, 10 filings were filed, from 5 insiders.
No insider bought on the market over the period, while 5 insiders filed 10 sales totalling €1.8M. Biggest ticket of the year: €715k, sold by 戴岚 and made public on 30 October 2026.
The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
With 10 filings in twelve months, the company is more active than the median of 2 filings across the 517 companies we follow on the same exchange. Our records for Bide Pharmatech Co., Ltd. go back to 2023, with 2 purchases and 10 sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +49.3%Entry CN¥36.16 · Close at T+365 CN¥54.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 79,000 shares@ CN¥504.017945.4% of flowA股XSHGSSE:273000001808411230
- 21,000 shares@ CN¥461.757320.0% of flowA股XSHGSSE:273000001750625380
- 1,000 shares@ CN¥618.077310.2% of flowA股XSHGSSE:273000001580436400
- 2,500 shares@ CN¥498.082419.9% of flowA股XSHGSSE:273000001471587200
- 9,500 shares@ CN¥460.268569.9% of flowA股XSHGSSE:273000001466505950
- 5,000 shares@ CN¥455.1715100.0% of flowA股XSHGSSE:273000001466505900
- 5,000 shares@ CN¥456.6211100.0% of flowA股XSHGSSE:273000001466505920
- 25,000 shares@ CN¥454.2052100.0% of flowA股XSHGSSE:273000001466506080
- 30,000 shares40.1% of flowA股XSHGSSE:273000000108253340
- 34,571 shares39.5% of flowA股XSHGSSE:273000000058700130
- 10,000 shares7.1% of flowA股XSHGSSE:173000007425911650Canonical exit: 24 Jun 2024 (T+90)
- 10,000 shares13.4% of flowA股XSHGSSE:173000006991511000Canonical exit: 7 Jan 2024 (T+90)
12 of 12 declarations
About Bide Pharmatech Co., Ltd.
毕得医药 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
